Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

62.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 119.60
  • 52 Week Low: 35.30
  • Currency: UK Pounds
  • Shares Issued: 540.14m
  • Volume: 417,457
  • Market Cap: £334.89m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.
Registrars: Capita Registrars

Key Personnel

CEO: Peter Butterfield
CFO: Andrew Franklin
Chairman: Jo Le Couilliard
Chief Operating Officer: Jeyan Heper
Independent Non-Executive Director: Martin Sutherland
Independent Non-Executive Director: Kristof Neirynck
Senior Independent Director: Richard Jones
Non-Executive Dir:

Contact Details

Address: Avonbridge House, Bath Road, Chippenham, Wiltshire, United Kingdom, SN15 2BB
Phone: +44 (0)1249 466966
Fax: +44 (0)1249 466977
Website: http://www.alliancepharma.co.uk

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0031030819

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 62.00p
Change Today 0.50p
% Change 0.81 %
52 Week High 119.60
52 Week Low 35.30
Volume 417,457
Shares Issued 540.14m
Market Cap £334.89m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.97% above the market average38.97% above the market average38.97% above the market average38.97% above the market average38.97% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Price Trend
12.72% below the market average12.72% below the market average12.72% below the market average12.72% below the market average12.72% below the market average
4.92% above the sector average4.92% above the sector average4.92% above the sector average4.92% above the sector average4.92% above the sector average
Income
29.95% below the market average29.95% below the market average29.95% below the market average29.95% below the market average29.95% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Growth
90.46% below the market average90.46% below the market average90.46% below the market average90.46% below the market average90.46% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 01-Jun-2023

Time Volume / Share Price
16:37 10,000 @ 62.00p
16:35 61,810 @ 62.00p
16:35 22 @ 62.00p
16:35 120 @ 62.00p
16:35 200 @ 62.00p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Jo Le Couilliard

Top of Page